Cord Blood Inventories Safe and Readily Available
Answers provided about cord blood and perinatal tissue banking during the pandemic
The Cord Blood Association has prepared answers to frequently asked questions about cord blood and perinatal tissue banking during the coronavirus pandemic. The questions generally center on the safety of current inventories, collections during the pandemic, and cord blood as an alternative when a matched living donor is unavailable for a transplant patient.
There’s also the intriguing question about whether cord blood, cord tissue or placenta tissue might be used in the manufacture of cell therapies to fight the COVID-19 virus.
Plans on Hold for 2020 'Cord Blood Connect'
Pause includes a moratorium on pre-registrations and abstract submissions
Given the rapidly evolving COVID-19 pandemic, a temporary moratorium has been placed on pre-registrations for the Cord Blood Connect international congress, scheduled for Sept. 10-12 in Miami Beach. The acceptance of abstracts also has been suspended while CBA leaders continue to assess the viability of this year’s congress.
Options being evaluated include re-scheduling, as well as alternatives for the in-person conference. Factors to be considered are the advice of public health authorities about in-person gatherings, governmental recommendations or restrictions on gatherings and travel, expectations for attendance, availability of faculty, support of sponsors and exhibitors, contracts that are in place with the venue and vendors – to name just a few.
The health and safety of attendees, faculty, sponsors, exhibitors and staff will always be the foremost concern.
